{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:47:42Z","timestamp":1775980062713,"version":"3.50.1"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3,25]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>GATA2 is a transcription factor critical for hematopoiesis. Germline mutations in GATA binding protein 2 (GATA2) led to haploinsufficiency, severe cytopenias of multiple cell lineages, susceptibility to infections and strong propensity to develop myelodysplastic syndrome, and acute myeloid leukemia. Mechanisms of progressive cytopenias remain unclear. MicroRNA (miRNA) represents a unique mechanism of post-transcriptional gene regulation. In this study, miRNA profiles were evaluated and eight miRNAs were found to be differentially expressed (\u22652-fold, P \u2264 0.05) in patient-derived cell lines (N\u00a0=\u00a013) in comparison to controls (N\u00a0=\u00a010). miR-9, miR-181a-2-3p, miR-181c, miR-181c-3p, miR-486-3p, and miR-582 showed increased expression, whereas miR-223 and miR-424-3p showed decreased expression. Cell death assays indicated that miR-181c potently induces cell death in lymphoid (Ly-8 and SP-53) and myeloid (HL-60) cell lines. miR-181c was predicted to target myeloid cell leukemia (MCL)1, which was confirmed by transfection assays, resulting in significantly reduced MCL1 mRNA and decreased live cell numbers. Bone marrow analysis of 34 GATA2 patients showed significantly decreased cellularity, CD34-positive cells, monocytes, dendritic cells, NK cells, B cells, and B cell precursors in comparison to healthy controls (N\u00a0=\u00a029; P\u00a0&amp;lt;\u00a00.001 for each), which was accompanied by decreased levels of MCL1 (P\u00a0&amp;lt;\u00a00.05). GATA2 expression led to significant repression of miR-181c expression in transfection experiments. Conversely, knockdown of GATA2 led to increased miR-181c expression. These findings indicate that miR-181c expression is increased and MCL1 levels decreased in GATA2 deficiency cells, and that GATA2 represses miR-181c transcription. Increased miR-181c may contribute to elevated cell death and cytopenia in GATA2 deficiency potentially through down-regulation of MCL1.<\/jats:p>","DOI":"10.1002\/jlb.2a1220-824r","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T20:16:22Z","timestamp":1626466582000},"page":"805-816","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["miR-181c regulates MCL1 and cell survival in GATA2 deficient cells"],"prefix":"10.1093","volume":"111","author":[{"given":"Weixin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center , Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Beijing Tong-Ren Hospital, Capital Medical University , Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephenie","family":"Droll","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center , Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Barber","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center , Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layla","family":"Saleh","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center , Bethesda, Maryland, USA"},{"name":"Hematology Section, Clinical Pathology Department, Faculty of Medicine, Mansoura University , Mansoura, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Corrigan-Cummins","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center , Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Trick","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center , Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vollter","family":"Anastas","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center , Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nga Voong","family":"Hawk","sequence":"additional","affiliation":[{"name":"Experimental Transplantation and Immunology Branch, National Cancer Institute (NCI), NIH , Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center , Bethesda, Maryland, USA"},{"name":"Department of Pathology & Laboratory Medicine, Weill Cornell Medical College , New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald C","family":"Vinh","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH , Bethesda, MD, USA"},{"name":"Division of Infectious Diseases, McGill University Health Centre , Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Hsu","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH , Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis D","family":"Hickstein","sequence":"additional","affiliation":[{"name":"Immune Deficiency Cellular Therapy Program, Center for Cancer Research, NCI, NIH , Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M","family":"Holland","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH , Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine R","family":"Calvo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center , Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1182\/blood.V89.10.3636","article-title":"Transcription factor GATA-2 is required for proliferation\/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation","volume":"89","author":"Tsai","year":"1997","journal-title":"Blood"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2011.04.007","article-title":"The role of the GATA2 transcription factor in normal and malignant hematopoiesis","volume":"82","author":"Vicente","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/bloodadvances.2018017137","article-title":"GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells","volume":"2","author":"Jung","year":"2018","journal-title":"Blood Adv"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1172\/JCI61623","article-title":"Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity","volume":"122","author":"Johnson","year":"2012","journal-title":"J Clin Invest"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.stemcr.2019.07.005","article-title":"Gata2 as a crucial regulator of stem cells in adult hematopoiesis and acute myeloid leukemia","volume":"13","author":"Menendez-Gonzalez","year":"2019","journal-title":"Stem Cell Rep"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1159\/000335770","article-title":"Adenosine promotes GATA-2-regulated p53 gene transcription to induce HepG2 cell apoptosis","volume":"28","author":"Yaguchi","year":"2011","journal-title":"Cell Physiol Biochem"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"e0131577","DOI":"10.1371\/journal.pone.0131577","article-title":"The LMO2 -25 region harbours GATA2-dependent myeloid enhancer and RUNX-dependent T-lymphoid repressor activity","volume":"10","author":"Bonadies","year":"2015","journal-title":"PloS One"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ajcp\/aqz067","article-title":"Germline predisposition to hematolymphoid neoplasia","volume":"152","author":"Weinberg","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","article-title":"GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia","volume":"125","author":"Ganapathi","year":"2015","journal-title":"Blood"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3324\/haematol.2011.041152","article-title":"Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications","volume":"96","author":"Calvo","year":"2011","journal-title":"Haematologica"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.seminhematol.2017.05.002","article-title":"GATA2 deficiency and related myeloid neoplasms","volume":"54","author":"Wlodarski","year":"2017","journal-title":"Semin Hematol"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bbmt.2018.01.030","article-title":"Allogeneic hematopoietic stem cell transplantation for GATA2 deficiency using a busulfan-based regimen","volume":"24","author":"Parta","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molmed.2010.04.001","article-title":"Roles of small RNAs in tumor formation","volume":"16","author":"Di Leva","year":"2010","journal-title":"Trends Mol Med"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA gene expression deregulation in human breast cancer","volume":"65","author":"Iorio","year":"2005","journal-title":"Cancer Res"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2011-01-330704","article-title":"Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome","volume":"118","author":"Zuo","year":"2011","journal-title":"Blood"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.leukres.2005.09.001","article-title":"Hematopoietic-specific microRNA expression in human cells","volume":"30","author":"Ramkissoon","year":"2006","journal-title":"Leuk Res"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0609.2008.01111.x","article-title":"Differential expression of microRNAs in hematopoietic cell lineages","volume":"81","author":"Merkerova","year":"2008","journal-title":"Eur J Haematol"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbrc.2006.07.207","article-title":"Human microRNA clusters: genomic organization and expression profile in leukemia cell lines","volume":"349","author":"Yu","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nm.2054","article-title":"Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype","volume":"16","author":"Starczynowski","year":"2010","journal-title":"Nat Med"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/leu.2016.181","article-title":"Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia","volume":"31","author":"Saleh","year":"2017","journal-title":"Leukemia"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3324\/haematol.2011.048132","article-title":"MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response","volume":"97","author":"Wang","year":"2012","journal-title":"Haematologica"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/10428199509059672","article-title":"mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines","volume":"19","author":"Chang","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/1097-0142(19890915)64:6<1248::AID-CNCR2820640614>3.0.CO;2-5","article-title":"The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma","volume":"64","author":"Daibata","year":"1989","journal-title":"Cancer"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"11720","DOI":"10.1523\/JNEUROSCI.1932-08.2008","article-title":"Identification of dynamically regulated microRNA and mRNA networks in developing oligodendrocytes","volume":"28","author":"Lau","year":"2008","journal-title":"J Neurosci"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3109\/10428190903147645","article-title":"Hematopoiesis-related microRNA expression in myelodysplastic syndromes","volume":"50","author":"Pons","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/onc.2014.274","article-title":"MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets","volume":"34","author":"Su","year":"2015","journal-title":"Oncogene"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cancergen.2014.12.006","article-title":"The pathological role and prognostic impact of miR-181 in acute myeloid leukemia","volume":"208","author":"Weng","year":"2015","journal-title":"Cancer Genet"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/cdd.2013.145","article-title":"Transcriptional fine-tuning of microRNA-223 levels directs lineage choice of human hematopoietic progenitors","volume":"21","author":"Vian","year":"2014","journal-title":"Cell Death Differ"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/cr.2010.134","article-title":"miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-beta","volume":"20","author":"Sun","journal-title":"Cell Res"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.4049\/jimmunol.1202897","article-title":"MiR-223 deficiency increases eosinophil progenitor proliferation","volume":"190","author":"Lu","year":"2013","journal-title":"J Immunol"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/leu.2013.357","article-title":"miR-9 is a tumor suppressor in pediatric AML with t(8;21)","volume":"28","author":"Emmrich","year":"2014","journal-title":"Leukemia"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1073\/pnas.1302645110","article-title":"Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis","volume":"110","author":"Senyuk","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.1091903","article-title":"MicroRNAs modulate hematopoietic lineage differentiation","volume":"303","author":"Chen","year":"2004","journal-title":"Science"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1182\/blood-2011-10-386235","article-title":"Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML","volume":"119","author":"Li","year":"2012","journal-title":"Blood"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2011.08581.x","article-title":"Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes","volume":"153","author":"Sokol","year":"2011","journal-title":"Br J Haematol"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"e59532","DOI":"10.1371\/journal.pone.0059532","article-title":"Prognostic role of microRNA-181a\/b in hematological malignancies: a meta-analysis","volume":"8","author":"Lin","year":"2013","journal-title":"PloS One"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/carcin\/bgs179","article-title":"miR-181a\/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes","volume":"33","author":"Zhu","year":"2012","journal-title":"Carcinogenesis"},{"key":"2023032109034089400_","first-page":"185","article-title":"hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells","author":"Shi","year":"1236","journal-title":"Brain Res"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/mol.110.066258","article-title":"Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia","volume":"78","author":"Zimmerman","year":"2010","journal-title":"Mol Pharmacol"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mito.2011.09.001","article-title":"miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes","volume":"12","author":"Ouyang","year":"2012","journal-title":"Mitochondrion"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"19807","DOI":"10.18632\/oncotarget.4415","article-title":"miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Emicro-TCL1 mouse model","volume":"6","author":"Bresin","year":"2015","journal-title":"Oncotarget"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.1106114","article-title":"Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells","volume":"307","author":"Opferman","year":"2005","journal-title":"Science"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1182\/blood-2009-12-258095","article-title":"The human stem cell hierarchy is defined by a functional dependence on Mcl-1 for self-renewal capacity","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood.V89.2.630","article-title":"Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions","volume":"89","author":"Zhou","year":"1997","journal-title":"Blood"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.tcb.2019.03.004","article-title":"Molecular comprehension of Mcl-1: from gene structure to cancer therapy","volume":"29","author":"Senichkin","year":"2019","journal-title":"Trends Cell Biol"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-020-01007-9","article-title":"MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents","volume":"13","author":"Bolomsky","year":"2020","journal-title":"J Hematol Oncol"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature02067","article-title":"Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1","volume":"426","author":"Opferman","year":"2003","journal-title":"Nature"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1101\/gad.14.1.23","article-title":"Mcl-1 deficiency results in peri-implantation embryonic lethality","volume":"14","author":"Rinkenberger","year":"2000","journal-title":"Genes Dev"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.celrep.2016.02.039","article-title":"Loss of a single Mcl-1 allele inhibits MYC-driven lymphomagenesis by sensitizing Pro-B cells to","volume":"14","author":"Grabow","year":"2016","journal-title":"Apoptosis Cell Rep"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1101\/gad.182980.111","article-title":"Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia","volume":"26","author":"Glaser","year":"2012","journal-title":"Genes Dev"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1182\/blood-2014-09-601567","article-title":"MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice","volume":"124","author":"Grabow","year":"2014","journal-title":"Blood"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/nar\/gkt848","article-title":"A regulatory circuit comprising GATA1\/2 switch and microRNA-27a\/24 promotes erythropoiesis","volume":"42","author":"Wang","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"e1006259","DOI":"10.1371\/journal.pgen.1006259","article-title":"The PU.1-modulated microRNA-22 is a regulator of monocyte\/macrophage differentiation and acute myeloid leukemia","volume":"12","author":"Shen","year":"2016","journal-title":"PLoS Genet"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.116.022478","article-title":"MicroRNA-based therapy of GATA2-deficient vascular disease","volume":"134","author":"Hartmann","year":"2016","journal-title":"Circulation"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"e55186","DOI":"10.1371\/journal.pone.0055186","article-title":"TGF-beta\/Smad2\/3 signaling directly regulates several miRNAs in mouse ES cells and early embryos","volume":"8","author":"Redshaw","year":"2013","journal-title":"PloS One"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/carcin\/bgq013","article-title":"Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis","volume":"31","author":"Hashimoto","year":"2010","journal-title":"Carcinogenesis"},{"key":"2023032109034089400_","first-page":"57","article-title":"The ENCODE Project Consortium: an integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2016","journal-title":"Nature"},{"key":"2023032109034089400_","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1093\/nar\/gkr604","article-title":"Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data","volume":"39","author":"Chien","year":"2011","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/JLB.2A1220-824R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/JLB.2A1220-824R","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/111\/4\/805\/49468296\/jlb10989.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/111\/4\/805\/49468296\/jlb10989.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T04:52:32Z","timestamp":1699246352000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/111\/4\/805\/6885117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,7,16]]},"published-print":{"date-parts":[[2022,3,25]]}},"URL":"https:\/\/doi.org\/10.1002\/jlb.2a1220-824r","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4]]},"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"2021-07-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}